PLUS THERAPEUTICS, Inc. Common Stock (PSTV) is a publicly traded Healthcare sector company. As of May 19, 2026, PSTV trades at $5.96 with a market cap of $36.03M and a P/E ratio of -19.12. PSTV moved +3.85% today. Year to date, PSTV is -57.91%; over the trailing twelve months it is -44.38%. Its 52-week range spans $2.90 to $57.75. Analyst consensus is strong buy with an average price target of $38.00. Rallies surfaces PSTV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
PSTV financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. PSTV recently traded at $5.96. Market cap is $36.03M. P/E ratio is -19.12. Revenue is $5.21M.
| Metric | Value |
|---|---|
| Price | $5.96 |
| Market Cap | $36.03M |
| P/E Ratio | -19.12 |
| EPS | $-0.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $57.75 |
| 52-Week Low | $2.90 |
| Volume | 81.82K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.21M |
| Net Income | $-22.39M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $5.21M | $-22.39M | $-0.29 |
| 2024 | $5.82M | $-12.98M | $-1.95 |
| 2023 | $4.91M | $-13.32M | $-4.24 |
| 2022 | $224.00K | $-20.27M | $-0.77 |
5 analysts cover PSTV: 0 strong buy, 4 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $38.00.